India

Primary tabs

Country: 
India
Working Group(s) / Area(s) of Work: 
Women & ESCR
Social Movements & Grassroots Groups
Economic Policy

The action arose from an appeal of two High Court decisions that were issued in 2016. A local women’s group (Mahila Mandals) and other self-help groups challenged the validity of a tender notice issued by the state of Maharashtra that year. The tender awarded a contract to large corporations with strong political connections for the supply of nutritional food supplements to beneficiaries under the ICDS.

Anil Kumar Mahajan joined the Indian Administrative Service (IAS) in 1977, starting a career in which he was subjected to multiple suspensions and, ultimate, forcible retirement in connection with a mental health disability. He was placed under suspension from February 17-24, 1988. From February 24, 1988 until February 24, 1990, he was suspended a second time. He was placed under a third suspension on May 20, 1993, subjected to official inquiries, and ordered to appear before a Medical Board.

The petitioner, Sandesh Bansal, is a health activist and member of Jan Adhikaar Manch, a nongovernmental organization (NGO) working to raise concern over the high maternal mortality rate (MMR) in Madhya Pradesh as a part of their “Save our Mothers” campaign. The case was also part of Human Rights Law Network’s (HRLN’s) national litigation strategy to address India’s high maternal mortality and morbidity rates. Petitioner alleged that the state failed to provide basic and adequate maternal healthcare.

This case concerns the constitutionality of Section 3(d) of the 2005 Amendment (“Amendment”) to India’s Patent Law, which was added to comply with Trade-Related Aspects of Intellectual Property Rights (TRIPS) and World Trade Organization’s (WTO) minimum standards for protecting intellectual property.  Section 3(d) requires that inventions based on a known substance be patentable only if they show the “enhanced efficacy” of the known substance.  Novartis, a large pharmaceutical company, submitted a patent application for its leukemia medication, Gleevec.  Novartis’ application was denied on

* Following discussions within ESCR-Net’s membership on climate and environmental justice and human rights in relation to the COVID-19 crisis, multiple members co-authored short articles in this context, including the following piece which was originally published on...

Statement: "India’s COVID-19 Lockdown: Human Rights Assessment and Compilation of State Relief Measures"

New Delhi, 5 May 2020

>> https://www.hlrn.org.in/documents/...

Developed by an ESCR-Net Member

In August 2008, the Ministry of Health and Family Welfare’s NACO developed an “Office Memorandum” in response to a public interest litigation (PIL), in which the Supreme Court reviewed the steps taken by NACO to combat HIV/AIDS and the services being provided to patients. The Supreme Court had issued directives, including those aimed at improving the sufficiency of centres distributing second line anti-retroviral therapy (ART).